Logo Image
  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
Feature|Articles|August 21, 2024 (Updated: August 21, 2024)

Following FDA Rejection, Experts Discuss MDMA Therapy, Improving Care for Veterans With PTSD

The FDA's decision to reject midomafetamine (MDMA) capsules in combination with assisted psychotherapy (MDMA-AT) for adults with PTSD reignited the controversial conversation around investigative psychedelic therapy.

The FDA's decision to reject midomafetamine (MDMA) capsules in combination with assisted psychotherapy (MDMA-AT) for adults with posttraumatic stress disorder (PTSD) reignited the controversial conversation around investigative psychedelic therapy.